Concepedia

Author

Adriana Zingone

National Cancer InstituteORCID

Also Known As

A Zingone, A. Zingone, Adriana Zingone, Zingone, Adriana

114

Publications

3.3K

Citations

30

H-Index

68

Concepts

All Affiliations

National Cancer InstituteCenter for Cancer ResearchNational Institutes of HealthMemorial Sloan Kettering Cancer CenterNational Institutes of Health Clinical Center
AZ

About

Adriana Zingone is an author at National Cancer Institute specializing in medicine, pathology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

20

807

2

Public Health

3

3

177

3

Health Sciences

2

2

76

4

Biostatistics

2

2

111

5

African American Studies

1

1

16

Adriana Zingone

×

52

Publications

2.9K

Citations

28

H-Index

YearCitations

Assessment of Variability in the SOMAscan Assay

Julián Candia, Foo Cheung, Yuri Kotliarov,

Scientific Reports

2017

395

Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma

Neha Korde, Mark Roschewski, Adriana Zingone,

JAMA Oncology

2015

308

Classical and/or alternative NF-κB pathway activation in multiple myeloma

Yulia N. Demchenko, O K Glebov, Adriana Zingone,

Blood

2010

289

Control of Autophagic Cell Death by Caspase-10 in Multiple Myeloma

Laurence Lamy, Vu N. Ngo, N. C. Tolga Emre,

Cancer Cell

2013

215

Comparative Transcriptome Profiling Reveals Coding and Noncoding RNA Differences in NSCLC from African Americans and European Americans

Khadijah A. Mitchell, Adriana Zingone, Leila Toulabi,

Clinical Cancer Research

2017

110

Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study

Benjamin M. Cherry, Neha Korde, Mary Kwok,

Leukemia & lymphoma/Leukemia and lymphoma

2013

99

Correction of Glycogen Storage Disease Type 1a in a Mouse Model by Gene Therapy

Adriana Zingone, Hisayuki Hiraiwa, Chi‐Jiunn Pan,

Journal of Biological Chemistry

2000

79

Eef1a2 Promotes Cell Growth, Inhibits Apoptosis and Activates JAK/STAT and AKT Signaling in Mouse Plasmacytomas

Zhaoyang Li, Chen‐Feng Qi, Dong‐Mi Shin,

PLoS ONE

2010

76

Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma

Amelia L. Parker, Elise D. Bowman, Adriana Zingone,

Genome Medicine

2022

76

A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression

Christina M. Annunziata, Lídia Hernandez, R. Eric Davis,

Blood

2010

75

Page 1